2018
Sanjay Kalra; Leszek Czupryniak; Gary Kilov; Roberta Lamptey; Ajay Kumar; A. G. Unnikrishnan; Aissa Boudiba; Mohamed Abid; Zhanay A. Akanov; Ali Latheef; Mustafa Araz; Ralph Audehm; Silver Bahendeka; Naby Balde; Sandeep Chaudhary; Chaicharn Deerochanawong; Olufemi Fasanmade; Hinde Iraqi; Tint Swe Latt; Jean Claude Mbanya; Joel Rodriguez-Saldana; Ko Seung Hyun; Zafar A. Latif; Maxim Lushchyk; Magdy Megallaa; Mohammed Wali Naseri; Nguyen Quang Bay; Kaushik Ramaiya; Hoosen Randeree; Syed Abbas Raza; Khalid Shaikh; Dina Shrestha; Eugene Sobngwi; Noel Somasundaram; Norlela Sukor; Rima Tan
Expert Opinion: Patient Selection for Premixed Insulin Formulations in Diabetes Care Article de journal
Dans: Diabetes Therapy, vol. 9, iss. 6, p. 2185-2199, 2018, ISSN: 1869-6953.
Résumé | Liens | BibTeX | Étiquettes: BIAsp, Coformulation, IDegAsp, Insulin initiation, Insulin intensification, LisproMix, Patient-centered, Premixed, type 2 diabetes
@article{Kalra2018,
title = {Expert Opinion: Patient Selection for Premixed Insulin Formulations in Diabetes Care},
author = {Sanjay Kalra and Leszek Czupryniak and Gary Kilov and Roberta Lamptey and Ajay Kumar and A. G. Unnikrishnan and Aissa Boudiba and Mohamed Abid and Zhanay A. Akanov and Ali Latheef and Mustafa Araz and Ralph Audehm and Silver Bahendeka and Naby Balde and Sandeep Chaudhary and Chaicharn Deerochanawong and Olufemi Fasanmade and Hinde Iraqi and Tint Swe Latt and Jean Claude Mbanya and Joel Rodriguez-Saldana and Ko Seung Hyun and Zafar A. Latif and Maxim Lushchyk and Magdy Megallaa and Mohammed Wali Naseri and Nguyen Quang Bay and Kaushik Ramaiya and Hoosen Randeree and Syed Abbas Raza and Khalid Shaikh and Dina Shrestha and Eugene Sobngwi and Noel Somasundaram and Norlela Sukor and Rima Tan},
url = {https://doi.org/10.1007/s13300-018-0521-2 http://link.springer.com/10.1007/s13300-018-0521-2},
doi = {10.1007/s13300-018-0521-2},
issn = {1869-6953},
year = {2018},
date = {2018-01-01},
journal = {Diabetes Therapy},
volume = {9},
issue = {6},
pages = {2185-2199},
publisher = {Springer Healthcare},
abstract = {Premixed insulins are an important tool for glycemic control in persons with diabetes. Equally important in diabetes care is the selection of the most appropriate insulin regimen for a particular individual at a specific time. Currently, the choice of insulin regimens for initiation or intensification of therapy is a subjective decision. In this article, we share insights, which will help in rational and objective selection of premixed formulations for initiation and intensification of insulin therapy. The glycemic status and its variations in a person help to identify the most appropriate insulin regimen and formulation for him or her. The evolution of objective glucometric indices has enabled better glycemic monitoring of individuals with diabetes. Management of diabetes has evolved from a ‘glucocentric’ approach to a ‘patient-centered’ approach; patient characteristics, needs, and preferences should be evaluated when considering premixed insulin for treatment of diabetes. Funding: Novo Nordisk, India.},
keywords = {BIAsp, Coformulation, IDegAsp, Insulin initiation, Insulin intensification, LisproMix, Patient-centered, Premixed, type 2 diabetes},
pubstate = {published},
tppubtype = {article}
}